# K143457: NeuroBlate System

- Pathway: 510(k) (Special)
- Applicant: Monteris Medical, Inc.
- Decided: Feb 19, 2015 after 78 days
- Product code: GEX (Powered Laser Surgical Instrument)
- Device class: 2
- Regulation: 21 CFR 878.4810
- Recalls of this device: 1 (1 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 8 generations back to K983831 (1999). 26 ancestors in all.
17 later devices descend from it; 4 cite it directly.
2 of 44 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K141983: Neuroblate System, Monteris Medical Corp. (2014) Summary page 4.

## Most influential descendants
- K162762: NeuroBlate System (2016), 16 descendants of its own
- K170724: NeuroBlate System (2017), 15 descendants of its own
- K171255: Monteris Medical NeuroBlate System (2017), 14 descendants of its own
- K172881: NeuroBlate System (2017), 13 descendants of its own
- K173305: NeuroBlate System (2017), 12 descendants of its own

## Recalls of this device
- Mar 25, 2016 · Class I · Z-1614-2016: Monteris received a report that the sapphire lens on a 2.2SF probe fractured during a LITT procedure, with resulting introduction of C02 into the patient's brain.

## Indications for use
The Monteris Medical NeuroBlate™ System is indicated for use to ablate, necrotize, or coagulate soft tissue through interstitial irradiation or thermal therapy in medicine and surgery in the discipline of neurosurgery with 1064 nm lasers. The Monteris Medical NeuroBlate™ System is intended for planning and monitoring thermal therapies under MRI visualization. It provides MRI based trajectory planning assistance for the stereotaxic placement of MRI compatible (conditional) NeuroBlate™ Laser Delivery Probes. It also provides real time thermographic analysis of selected MRI images. When interpreted by a trained physician, this System provides information that may be useful in the determination or assessment of thermal therapy. Patient management decisions should not be made solely on the basis of the NeuroBlate™ System analysis.

Source page: https://510kreport.com/device/K143457
Methodology: https://510kreport.com/methodology